We are live on ! Find out more
TNGX icon

Tango Therapeutics
TNGX

72 hedge funds and large institutions have $528M invested in Tango Therapeutics in 2022 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 23 increasing their positions, 11 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

233% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 6

109% more repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 11

24% more funds holding

Funds holding: 58 → 72 (+14)

2.18% more ownership

Funds ownership: 77.41% → 79.59% (+2.2%)

25% less funds holding in top 10

Funds holding in top 10: 4 → 3 (-1)

29% less capital invested

Capital invested by funds: $741M → $528M (-$213M)

Holders
72
Holders Change
+14
Holders Change %
+24.14%
% of All Funds
1.14%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.05%
New
20
Increased
23
Reduced
11
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$11M
2
TCM
TCG Crossover Management
California
+$10.9M
3
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$8.67M
4
SCA
Southpoint Capital Advisors
New York
+$6.98M
5
Millennium Management
Millennium Management
New York
+$4.21M

Top Sellers

Rank Fund Capital Flow
1
HA
HHLR Advisors
Cayman Islands
-$25.9M
2
EC
EcoR1 Capital
California
-$4.66M
3
Fidelity Investments
Fidelity Investments
Massachusetts
-$2.65M
4
RI
RTW Investments
New York
-$1.98M
5
Citadel Advisors
Citadel Advisors
Florida
-$546K
Name Holding Trade Value Shares
Change 		Change in
Stake
JP Morgan Chase
51
JP Morgan Chase
New York
$199K -$54.6K -6,298 -19%
Bank of New York Mellon
52
Bank of New York Mellon
New York
$191K – – –
CS
53
Credit Suisse
Switzerland
$191K +$15.3K +1,762 +8%
LP
54
LMR Partners
United Kingdom
$190K -$117K -13,459 -35%
Charles Schwab
55
Charles Schwab
California
$185K – – –
YIH
56
Y-Intercept (HK)
Hong Kong
$154K +$176K +20,305 New
SC
57
Shay Capital
New York
$133K +$152K +17,500 New
MFS
58
Mirabella Financial Services
United Kingdom
$126K +$145K +16,674 New
Morgan Stanley
59
Morgan Stanley
New York
$119K +$59.6K +6,878 +78%
GCP
60
GSA Capital Partners
United Kingdom
$113K +$129K +14,900 New
UBS AM
61
UBS AM
Illinois
$92.5K – – –
OMC
62
Old Mission Capital
Illinois
$89K +$102K +11,729 New
Legal & General Group
63
Legal & General Group
United Kingdom
$86K – – –
ASRS
64
Arizona State Retirement System
Arizona
$81K +$468 +54 +0.5%
IC
65
Ikarian Capital
Texas
$42K +$2.39K +276 +5%
Royal Bank of Canada
66
Royal Bank of Canada
Ontario, Canada
$32K +$36.2K +4,181 New
PCM
67
Penserra Capital Management
California
$18K +$442 +51 +2%
UBS Group
68
UBS Group
Switzerland
$16K -$4.63K -534 -21%
OCM
69
Ovata Capital Management
Hong Kong
$7K +$7.8K +900 New
Wells Fargo
70
Wells Fargo
California
$3K +$9 +1 +0.3%
TRCT
71
Tower Research Capital (TRC)
New York
$1K +$867 +100 New
RI
72
RTW Investments
New York
– -$1.98M -180,819 Closed
Janney Montgomery Scott
73
Janney Montgomery Scott
Pennsylvania
– -$438K -40,000 Closed
JG
74
Jefferies Group
New York
– -$410K -37,483 Closed
NFGH
75
Nan Fung Group Holdings
Hong Kong
– -$279K -25,500 Closed
1 2
3
4

TNGX Hedge Fund Activity: Q1 2022 in Review

72 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Tango Therapeutics (TNGX) for Q1 2022, worth a combined $528M — down 29% from $741M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new TNGX positions and 6 closed out — a net gain of 14 holders — while 23 added to existing stakes and 11 trimmed.

The largest buyer was Vanguard Group, adding an estimated $11M. The largest seller was HHLR Advisors, cutting an estimated $25.9M.

  • 72 institutional investors held Tango Therapeutics (TNGX) as of Q1 2022, up from 58 in Q4 2021.
  • Funds reported $528M of Tango Therapeutics stock for Q1 2022, down 29% quarter-over-quarter.
  • 20 funds opened new Tango Therapeutics positions in Q1 2022 and 6 closed out, a net change of +14 holders.
  • The largest Tango Therapeutics buyer in Q1 2022 was Vanguard Group, an estimated $11M added.
  • The largest Tango Therapeutics seller in Q1 2022 was HHLR Advisors, an estimated $25.9M sold.

Based on aggregated 13F filings for Q1 2022.